As your partner in health and safety, we are continuously monitoring regulatory updates that may affect your operations. See the ECDC's latest COVID-19 updates and resources below.

COVID-19 Rail Protocol

ECDC released recommendations and an infographic for safe resumption of railway services in Europe. This protocol reflects the current status of knowledge about the COVID-19 disease and its pandemic effect. In addition, it summarizes preventive measures considered effective at the date of publication (July 21, 2020), and complements measures taken by the European Commission to support Member States in re-launching mobility and tourism across Europe.

https://www.ecdc.europa.eu/en/publications-data/covid-19-rail-protocol

Use of Gloves in Healthcare and Non-Healthcare Settings in the Context Of COVID-19

ECDC released a document to provide scientific evidence and guidance document (attached) and infographic (attached) for healthcare settings and the public on using gloves as a preventive measure during the COVID-19 pandemic. Key messages include:

In the Community

  • There is currently insufficient evidence to recommend the regular use of gloves as a preventive measure in the context of COVID-19 to the public and to people in most occupations.
  • Use of gloves in the community may lead to the misconception that hand hygiene practices can be neglected.
  • Regular use of gloves may confer the risk of dermatological side effects.
  • The generation of waste from unnecessary glove use causes environmental damage.

In Healthcare Settings

  • The use of medical gloves is recommended as part of standard precautions to reduce the risk of contamination of healthcare workers’ hands with blood and other body fluids including contact with non-intact skin and mucous membranes.
  • When indicated, use of medical gloves is recommended as part of contact precautions, to reduce the risk of pathogen dissemination to the patient’s environment, to other patients and for the protection of healthcare workers.
  • Taking into consideration the currently available types of gloves for use in healthcare settings, extended use, decontamination and reuse of single-use medical gloves is discouraged.
  • In the event of shortages, single-use medical gloves should be prioritized for use in healthcare settings.

https://www.ecdc.europa.eu/en/publications-data/infographic-use-gloves-healthcare-and-non-healthcare-settings-context-covid-19

  

Provision of Support for Medically and Socially Vulnerable Populations

ECDC released a document to provide guidance for civil society and non-governmental organizations (NGOs) as well as for national and regional authorities in the European Union and European Economic Area (EU/EEA) and the United Kingdom (UK), who are providing support for people who have medical and social vulnerabilities during the coronavirus disease (COVID-19) pandemic. Specifically, it aims to identify some of the major cross-cutting challenges, successes and lessons learned by these organizations during the period of stay-at-home and other measures from March-May 2020. It is hoped that the findings presented may be applicable to support service providers across the EU/EEA and the UK as the pandemic evolves, and in particular in the event of an upsurge in cases over the coming months that necessitates a subsequent return to stay-at-home measures or other restrictions in movement.

https://www.ecdc.europa.eu/en/publications-data/guidance-medically-and-socially-vulnerable-populations-covid-19

Aviation Health Safety Protocol, 2nd update

ECDC and EASA issued an update to Aviation Health Safety Protocol and operational guidelines for the management of air passengers and aviation personnel in relation to the COVID-19 pandemic (attached). The purpose is to serve as an aviation health safety protocol and to provide a source of best practice on how airport operators, airplane operators conducting commercial and non-commercial passenger transport operations and national aviation authorities can ensure the health and safety of passengers, as well as the staff and crew who serve them, by maintaining safe and secure operations whilst minimizing the risk of virus transmission. This should complement the advice of public health authorities and help employers in their duties under the relevant legislation on protection of workers’ health and safety.

https://www.ecdc.europa.eu/en/publications-data/covid-19-aviation-health-safety-protocol

Heating, Ventilation and Air Conditioning (HVAC) Systems in the Context of COVID-19

ECDC released a guidance document describing current evidence of coronavirus transmission and HVAC systems. The role of ventilation in preventing COVID-19 transmission is not well-defined (i.e. by preventing dispersal of infectious particles to minimize the risk of transmission or preventing transfer of an infectious dose to susceptible individuals). COVID-19 is thought to be primarily transmitted via large respiratory droplets, however, an increasing number of outbreak reports implicate the role of aerosols in COVID-19 outbreaks. Aerosols consist of small droplets and droplet nuclei which remain in the air for longer than large droplets. In addition to preventative measures of physical distancing, hand hygiene, face coverings and cleaning/disinfecting routines, the following infection prevention measures are suggested:

  • Direct air flow should be diverted away from groups of individuals to avoid pathogen dispersion.
  • Avoid recirculating air as much as possible (refer to HVAC system manufacturer or technicians to assist).
  • Maintain the minimum number of air exchanges per hour in accordance with applicable building regulations. Increasing the number of air exchanges per hour will reduce risk of transmission in closed spaces.
  • As a general principle, mechanical ventilation should be arranged to minimize the direction of sustained air flow for stationary persons.

https://www.ecdc.europa.eu/en/publications-data/heating-ventilation-air-conditioning-systems-covid-19

Monitoring and Evaluation Framework for COVID-19 Response Activities

ECDC released a monitoring and evaluation framework to support EU and EEA countries and the UK in their efforts to monitor the implementation and effects of COVID-19 response activities. The framework presents indicators for a variety of key pillars of COVID-19 preparedness, prevention and control activities and provides guidance to countries on how to collect and analyze data for the suggested indicators. The strategic information provided by the indicators can assist decision makers at subnational, national and EU level to support preparedness and response planning, and in-action and after-action reviews. The framework will need to be adapted to local circumstances; the relevance of indicators depends on the specificities of the setting.

https://www.ecdc.europa.eu/en/publications-data/covid-19-monitoring-and-evaluation-framework-response-activities

Guidance for Migrant and Refugee Reception and Detention Centers

ECDC issued a guidance document to provide scientific advice on public health principles and considerations for infection and prevention control of COVID-19 in migrant and refugee reception and detention centers in the European Union and European Economic Area (EU/EEA) and the United Kingdom (UK). Topics covered include:

  • Whilst there is no evidence to suggest that SARS-CoV-2 transmission is higher amongst migrants and refugees, environmental factors such as overcrowding may increase their exposure to the disease.
  • All principles of hand hygiene and physical distancing applied in the community should be applied in migrant reception and detention settings. If physical distancing and risk-containment measures cannot be safely implemented, measures to de-congest and evacuate residents should be.
  • Providing free and equitable prevention, testing, treatment and care to migrants and refugees in settings of reception and detention is critical.
  • There is no evidence that quarantining whole camps effectively limits transmission of SARS-CoV-2.
  • Migrant and refugee reception and detention centers should be given priority for testing.
  • Communicating about the risks and prevention requires strategies that are adapted to meet the different language, cultural and literacy needs of the different populations.

https://www.ecdc.europa.eu/en/publications-data/covid-19-guidance-prevention-control-migrant-refugee-centres

Rapid Risk Assessment: COVID-19 in the EU/EEA – Tenth Update

ECDC updated their risk assessment to include:

  • Updated epidemiological and sero-epidemiological information;
  • Overview of response measures implemented in the EU/EEA countries and the UK;
  • Options for response to minimize the risk of resurgence of COVID-19.

https://www.ecdc.europa.eu/en/publications-data/rapid-risk-assessment-coronavirus-disease-2019-covid-19-pandemic-tenth-update

Passenger Locator Data

The ECDC issued a position paper with guidance to transportation operators, particularly airlines, to improve contact tracing. The scope of the document is to provide ECDC’s views on the passenger locator data required and the appropriate use of entry and exit screening procedures at points of entry (PoE), including health declaration forms, in the context of COVID-19 in the EU/EEA and the United Kingdom (UK). In depth descriptions include these topics:

  • In order for contact tracing to be successful and efficient, passenger locator data should become available to the public health authorities as soon as possible after the identification of a confirmed case among airline passengers.
  • Current evidence indicates that entry and/or exit screening at ports of entry, such as airports, is ineffective in preventing the spread of SARS-CoV-2 virus.
  • A health declaration form or health screening questionnaire is part of the exit or entry screening process targeting a specific disease and this needs to be assessed by a health professional with the objective of detecting cases in incoming passengers.
  • ECDC advises against combining passenger locator data and health declarations or health screening questionnaires in the same form, as this will delay the transfer of data and the contact tracing procedures.

https://www.ecdc.europa.eu/en/publications-data/passenger-locator-data-entry-exit-screening-health-declaration

Mobile Applications for Contact Tracing in EU/EEA

ECDC released a document intended to facilitate the dialogue between public health authorities and app developers to ensure that the main epidemiological and operational considerations are taken into account, while also understanding the technological limitations.

https://www.ecdc.europa.eu/en/publications-data/covid-19-mobile-applications-support-contact-tracing

Options for The Decontamination and Reuse of Respirators

Due to the COVID-19 pandemic induced worldwide shortage of respirators or filtering face pieces (FFP), ECDC has summarized the different procedures that have been tested for decontamination of respirators reuse decontamination methods and precautions for each method. FFPs should be prioritized for use in healthcare settings when aerosol-generating procedures (AGPs) are performed.

Guiding principles for reuse are:

  • Respirators which have been visibly contaminated (e.g. during procedure at intubated patients, such as suction cleaning of airways, taking probes, extubation attempts, etc.) or are damaged or not fitting, should be discarded and cannot be taken for re-use or decontamination procedures.
  • Respirators may be protected by a medical face mask in order to prevent soiling.
  • Use of new ‘expired respirators’ (manufacturers expiry date) is possible if they were properly stored until use.
  • One approach for reuse of respirators seems to be providing each healthcare worker with a set of minimum five respirators and rotate daily
  • Irrespective of which method of decontamination is applied, a fit-check prior to re-use is necessary. If the fit check is not passed, the respirator should be discarded.

See the Summary of the approaches for FFP decontamination and reuse: expected effect and limitations.

https://www.ecdc.europa.eu/en/publications-data/options-decontamination-and-reuse-respirators-covid-19-pandemic

  

Infection Prevention and Control for Primary Care, Dental and Pharmacy

ECDC released a technical report to prevent spread of COVID-19. Specific guidance is called out for:

  • General infection prevention and control training, measures, staffing and workplace considerations
  • Primary care clinics and practices regarding staffing, actions prior to patient arrival, during patient visit, patient follow-up and information, after the patient leaves
  • Dental offices and clinics before the patient arrives, during dental care, after the patient leaves
  • Pharmacies at the counter, for the customers, and home deliveries

https://www.ecdc.europa.eu/sites/default/files/documents/Infection-prevention-and-control-primary-care-dental-pharmacies.pdf

Conducting in-action and after-action reviews of the public health response to COVID-19

ECDC released a document aimed at supporting the implementation of after action reviews (AARs) focused on the public health response to COVID-19. Designed to strengthen preparedness and the current response, the document reviews the main phases of planning and conducting AARs and discusses specific considerations relevant to COVID-19.

https://www.ecdc.europa.eu/en/publications-data/conducting-action-and-after-action-reviews-public-health-response-covid-19

Air Travel Infographic Released

ECDC in conjunction with the EASA issued infographics (view here) to summarize air travel experience for passengers in the context of COVID-19.

https://www.ecdc.europa.eu/en/publications-data/poster-covid-19-plan-your-journey

COVID-19 Surveillance Tool: Methodology for Estimating Prevalence

ECDC released technical guidance tool for estimating the prevalence of SARS-CoV-2 infected cases, through a cross sectional study design based on pooled sampling for RT-PCR testing on a random population sample.

https://www.ecdc.europa.eu/sites/default/files/documents/Methodology-estimating-point-prevalence -SARS-CoV-2-infection-pooled-RT-PCR-testing.pdf

Projected Baselines of COVID-19 in the EU/EEA and UK

ECDC built mathematical models based on current knowledge to provide a short term 30 day forecast of expected number of COVID-19 cases, deaths and hospitalized cases (general hospital and intensive care).

https://www.ecdc.europa.eu/en/publications-data/projected-baselines-covid-19-eueea-and-uk-assessing-impact-de-escalation-measures

  

Considerations for Travel in the EU/EEA

ECDC updated travel guidance for public health authorities and EU/EEA member states and the UK. The document outlines principles for developing more individualized guidance or operating procedures related to travel in European countries. Travels in the named areas are to check with local authorities of the destinations and locations traveling through.

https://www.ecdc.europa.eu/sites/default/files/documents/Considerations-related-to-measures-for-travellers-reduce-spread-COVID-19-in-EUEEA.pdf

Aviation Health Safety Protocol

Guidance for the management of air travel in relation to the COVID-19 pandemic was released. Aviation health safety protocol and to provide a source of best practice on how airport operators, airplane operators conducting commercial and non-commercial passenger transport operations and national aviation authorities can ensure the health and safety of passengers, as well as the staff and crew who serve them, by maintaining safe and secure operations whilst minimizing the risk of virus transmission. Topics covered include:

  • Passenger Management including thermal screening, protective screens, check-in and boarding, onboard, disembarking
  • Crew management
  • Cleaning and disinfection
  • Use of masks

https://www.ecdc.europa.eu/en/publications-data/covid-19-aviation-health-safety-protocol

COVID-19 in Care Homes and Long-Term Care Facilities

Released an infographic for COVID-19 in care homes and technical document for Surveillance of COVID-19 at long term care facilities in the EU/EAA. The document assists with planning, implementation, and monitory systems at long term care facilities.

https://www.ecdc.europa.eu/en/covid-19-pandemic

Rapid Risk Assessment
 

A rare and severe condition in pediatric patients with COVID-19 has been identified and the ECDC characterized what is known to date and developed a questionnaire. While children appear to be less affected by COVID-19 overall, in total about 230 cases of Pediatric Inflammatory Multisystem Syndrome (PIMS). Cases present as a mix of symptoms similar to Kawasaki Disease and Toxic Shock Syndrome.

https://www.ecdc.europa.eu/en/publications-data/paediatric-inflammatory-multisystem-syndrome-and-sars-cov-2-rapid-risk-assessment

Update for Infection Prevention and Control Preparedness in Healthcare Settings

Changes to the current update have the following additions:

  • The recommendation that all healthcare staff providing care to patients in areas with community transmission should consider wearing surgical masks or FFP2 respirators, if available, in addition to practicing meticulous hand hygiene.
  • The clarification that the recommendation for long-term care facility (LTCF) staff not to come to work if they have symptoms compatible with COVID-19 also includes those with mild symptoms.
  • The recommendation that in areas with community transmission all LTCF staff who provide care for residents or have contact with residents or communal areas of the LTCF should consider wearing surgical masks or FFP2 respirators, in addition to practicing meticulous hand hygiene.
  • Additional references to current ECDC surveillance guidance for long-term care facilities recommending laboratory testing as soon as possible after the detection of a case, to guide infection prevention and control measures. If a suspected case is detected, samples should be tested from all suspected cases in residents and staff as a minimum, but preferably from all staff. If a laboratory-confirmed case is detected, all residents and staff should be tested, preferably with staff being tested weekly as a follow-up [1a].

https://www.ecdc.europa.eu/sites/default/files/documents/Infection-prevention-control-for-the-care-of-patients-with-2019-nCoV-healthcare-settings_third-update.pdf

ECDC Released Guidance Document for Contact Tracing

Document outlines the following:

  • Typical methods for contact tracing (i.e. phone conversations) and alternative methods (text or pre-recorded calls)
  • Repurposing of current infrastructure such as hotline and call center networks
  • Use of tracing management software, Web based apps, mobile tracing
  • Estimate of labor hours and staffing required based on number of cases reported, and best practices for that number of cases.

https://www.ecdc.europa.eu/en/publications-data/contact-tracing-covid-19-evidence-scale-up-assessment-resources

ECDC Released Guidance Document on Public Transportation Personal Protective Measures

Two main risk are transmission by crowding, risk of staff infection. The following measures are recommended:

  • Discourage sick passengers from using public transit
  • Ensure physical distancing for staff, ideally behind transparent barriers
  • Educational infographics for physical distancing hand hygiene, face coverings
  • Proper ventilation of the vehicle and avoid recirculating air
  • Cleaning and disinfection to follow previously established protocols

https://www.ecdc.europa.eu/sites/default/files/documents/COVID-19-public-transport-29-April-2020.pdf

  

ECDC Updated Their Guidance Document Regarding Supply of Products of Human Origin (Such as Blood, Plasma, Etc.)

Included new guidance regarding types of substances of human origin and risk assessment and management options for the safe and sustainable supply.

https://www.ecdc.europa.eu/sites/default/files/documents/COVID 19-supply-substances-human-origin-first-update.pdf

Go to top